Non-Laboratory-Based self-Assessment screening score for non-Alcoholic fatty liver disease: Development, validation and comparison with other scores

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Lee, Yong Ho ^a   Bang, Heejung ^b   Park, Young Min ^c   Bae, Ji Cheol ^d   Lee, Byung Wan ^a   Kang, Eun Seok ^a   Cha, Bong Soo ^a   Lee, Hyun Chul ^e   Balkau, Beverley ^e   Lee, Won Young ^f   Kim, Dae Jung ^g  

^a Yonsei University College of Medicine   (South Korea)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c National Health Insurance Corporation   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

^e CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^f Sungkyunkwan University School of Medicine   (South Korea)

^g Ajou University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ALCOHOL CONSUMPTION; ALGORITHM; AREA UNDER THE CURVE; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSLIPIDEMIA; ECHOGRAPHY; FAMILY HISTORY; FEMALE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; NON LABORATORY BASED SELF ASSESSMENT SCORE; NONALCOHOLIC FATTY LIVER; PHYSICAL ACTIVITY; PREDICTIVE VALUE; RISK ASSESSMENT; SCORING SYSTEM; SELF EVALUATION; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; ULTRASOUND SCANNER; VALIDATION STUDY; WAIST CIRCUMFERENCE; ANTHROPOMETRY; DRINKING BEHAVIOR; FATTY LIVER; FIBROSIS; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PATHOLOGY; SOUTH KOREA;

ADULT; ALCOHOL DRINKING; ANTHROPOMETRY; BODY MASS INDEX; DIABETES MELLITUS; DIAGNOSTIC SELF EVALUATION; FATTY LIVER; FEMALE; FIBROSIS; HUMANS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; REPUBLIC OF KOREA; WAIST CIRCUMFERENCE;

EID: 84942825732     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107584     Document Type: Article

References (40)

1. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-1231.
2. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, et al. (2012) The diagnosis and management of non-Alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55: 2005-2023.
3. Vernon G, Baranova A, Younossi ZM (2011) Systematic review: The epidemiology and natural history of non-Alcoholic fatty liver disease and nonalcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34: 274-285.
4. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, et al. (2011) Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-Aged population utilizing ultrasound and liver biopsy: A prospective study. Gastroenterology 140: 124-131.
5. Claridge LC (2011) Rising liver death rate: food for thought. Lancet 377: 2179-2180.
6. (2013) Liver disease in Europe. Lancet 381: 508.
7. Anstee QM, Targher G, Day CP (2013) Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 10: 330-344.
8. Musso G, Gambino R, Cassader M, Pagano G (2011) Meta-Analysis: natural history of non-Alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 43: 617-649.
9. Ong JP, Pitts A, Younossi ZM (2008) Increased overall mortality and liverrelated mortality in non-Alcoholic fatty liver disease. J Hepatol 49: 608-612.
10. Söderberg C, Sta l P, Askling J, Glaumann H, Lindberg G, et al. (2010) Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 51: 595-602.
11. Zhou YJ, Li YY, Nie YQ, Huang CM, Cao CY (2012) Natural course of nonalcoholic fatty liver disease in southern China: A prospective cohort study. J Dig Dis 13: 153-160.
12. Afdhal NH (2012) Management of nonalcoholic fatty liver disease: A 60-year-old man with probable nonalcoholic fatty liver disease: weight reduction, liver biopsy, or both? JAMA 308: 608-616.
13. Leung CM, Lai LS, Wong WH, Chan KH, Luk YW, et al. (2009) Non-Alcoholic fatty liver disease: An expanding problem with low levels of awareness in Hong Kong. J Gastroenterol Hepatol 24: 1786-1790.
14. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, et al. (2006) The Fatty Liver Index: A simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 6: 33
15. Kotronen A, Peltonen M, Hakkarainen A, Sevastianova K, Bergholm R, et al. (2009) Prediction of non-Alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology 137: 865-872.
16. Lee J, Kim D, Kim HJ, Lee C, Yang JI, et al. (2010) Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis 42: 503-508.
17. Bedogni G, Kahn HS, Bellentani S, Tiribelli C (2010) A simple index of lipid overaccumulation is a good marker of liver steatosis. BMC Gastroenterol 10: 98.
18. Park YJ, Lim JH, Kwon ER, Kim HK, Jung MC, et al. (2011) Development and validation of a simple index system to predict nonalcoholic fatty liver disease. Korean J Hepatol 17: 19-26.
19. Bae JC, Suh S, Rhee EJ, Park CY, Oh KW, et al. (2012) Regular exercise is associated with a reduction in the risk of NAFLD and decreased liver enzymes in individuals with NAFLD independent of obesity in Korean adults. PLoS ONE 7: e46819-e46819.
20. (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
21. Lee Y, Bang H, Kim HC, Park SW, Kim DJ (2012) A simple screening score for diabetes for the Korean population: development, validation, and comparison with other scores. Diabetes care 35: 1723-1730.
22. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, et al. (2002) The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123: 745-750.
23. Maldonado G, Greenland S (1993) Simulation study of confounder-selection strategies. American J Epidemiol 138: 923-936.
24. Oh SW (2011) Obesity and metabolic syndrome in Korea. Diabetes Metab J 35: 561-566.
25. Gonen M (2007) Analyzing Receiver Operating Characteristic Curves with SAS. SAS Institute, Cary, NC.
26. Bang H, Edwards AM, Bomback AS, Ballantyne CM, Brillon D, et al. (2009) Development and validation of a patient self-Assessment score for diabetes risk. Ann Intern Med 151: 775-783.
27. Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, et al. (2007) The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45: 846-854.
28. Farrell GC, Wong VW, Chitturi S (2013) NAFLD in Asia-As common and important as in the West. Nat Rev Gastroenterol Hepatol 10: 307-318.
29. Fabbrini E, Sullivan S, Klein S (2010) Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51: 679-689.
30. Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, et al. (2011) Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 9: 524-530. e521.
31. Ramos-De la Medina A, Remes Troche JM, Roesch Dietlen FB, Pérez-Morales AG, Martinez S, et al. (2008) Routine liver biopsy to screen for nonalcoholic fatty liver disease (NAFLD) during cholecystectomy for gallstone disease: is it justified? J Gastrointest Surg 12: 2097-2102.
32. Lee JY, Kim KM, Lee SG, Yu E, Lim Y, et al. (2007) Prevalence and risk factors of non-Alcoholic fatty liver disease in potential living liver donors in Korea: A review of 589 consecutive liver biopsies in a single center. J Hepatol 47: 239-244.
33. Wieckowska A, McCullough AJ, Feldstein AE (2007) Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology 46: 582-589.
34. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, et al. (2005) Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study. Hepatology 42: 44-52.
35. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, et al. (2000) Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 132: 112-117.
36. Tchernof A, Després J (2013) Pathophysiology of human visceral obesity: An update. Physiol Rev 93: 359-404.
37. Suzuki A, Abdelmalek MF (2009) Nonalcoholic fatty liver disease in women. Women's Health 5: 191-203.
38. Liu Y, Wang L, Li Z, Zhang H, Wu J, et al. (2013) Differential effects of estrogen/androgen on the prevention of nonalcoholic fatty liver disease in the male rat. J Lipid Res 54: 345-357.
39. Lee JW, Cho YK, Ryan M, Kim H, Lee SW, et al. (2010) Serum uric acid as a predictor for the development of nonalcoholic Fatty liver disease in apparently healthy subjects: A 5-year retrospective cohort study. Gut Liver 4: 378-383.
40. (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363: 157-163.